# Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant Glaucoma

> **NCT01361841** · NA · UNKNOWN · sponsor: **Centre de recherche du Centre hospitalier universitaire de Sherbrooke** · enrollment: 141 (estimated)

## Conditions studied

- Ocular Hypertension
- Primary Glaucoma

## Interventions

- **DRUG:** Latanoprost, bimatoprost, travoprost
- **DRUG:** travoprost, latanoprost and bimatoprost

## Key facts

- **NCT ID:** NCT01361841
- **Lead sponsor:** Centre de recherche du Centre hospitalier universitaire de Sherbrooke
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-01
- **Primary completion:** 2012-01
- **Final completion:** 2013-01
- **Target enrollment:** 141 (ESTIMATED)
- **Last updated:** 2011-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01361841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01361841, "Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant Glaucoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01361841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*